Ignite Creation Date:
2024-05-05 @ 4:37 PM
Last Modification Date:
2024-10-26 @ 9:22 AM
Study NCT ID:
NCT00272987
Status:
TERMINATED
Last Update Posted:
2023-04-28
First Post:
2006-01-04
Brief Title:
ErbB2 Over-expressing Metastatic Breast Cancer Study Using Paclitaxel Trastuzumab and Lapatinib
Sponsor:
Novartis Pharmaceuticals
Organization:
Novartis
Key Dates - Follows AllAPIJSON File Order
Start Date:
2005-12-13
Start Date Type:
ACTUAL
Primary Completion Date:
2009-07-31
Primary Completion Date Type:
ACTUAL
Completion Date:
2019-10-21
Completion Date Type:
ACTUAL
First Submit Date:
2006-01-04
First Submit QC Date:
January 5 2006
Study First Post Date:
2006-01-09
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
2014-08-20
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
2010-08-12
Disp First Submit QC Date:
November 3 2011
Disp First Post Date:
2011-11-10
Disp First Post Date Type:
ESTIMATED
Last Update Submit Date:
2023-04-27
Last Update Post Date:
2023-04-28
Last Update Post Date Type:
ACTUAL